EFDID: 355107EFD: View Filing

Issuer: GENEOS Therapeutics, Inc. (0001769177) - D

Accession: 0001769177-20-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001769177
  • Entity Name:
    GENEOS Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    660 WEST GERMANTOWN PIKE
    SUITE LL110
    PLYMOUTH MEETING, PA 19462
  • Persons:
    Related Persons 6
    Niranjan Y. Sardesai
    Executive Officer, Director
    James Eadie
    Director
    J. Joseph Kim
    Director
    Casey Cunningham
    Director
    Samuel Broder
    Director
    Sangwoo Lee
    Director
EDGAR: Offering Information
  • Accession Date:
    11/17/2020
  • First Sale Date:
    11/12/2020
  • Offering Amount:
    $11,999,995
  • Amount Sold:
    $10,399,998
  • Amount Remaining:
    $1,599,997
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:MA, PA, TX, VA, WI
Inactive:NE
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
GENEOS Therapeutics, Inc./s/ Niranjan Y. SardesaiNiranjan Y. SardesaiPresident and Chief Executive Officer2020-11-17